Skip to main content

Table 6 Screening assessment

From: Study Protocol: The Norfolk Diabetes Prevention Study [NDPS]: a 46 month multi - centre, randomised, controlled parallel group trial of a lifestyle intervention [with or without additional support from lay lifestyle mentors with Type 2 diabetes] to prevent transition to Type 2 diabetes in high risk groups with non - diabetic hyperglycaemia, or impaired fasting glucose

NDPS screening assessment - appointment 1

Ethnicity

Smoking status

Waist circumference [cm]

Height [cm]

Weight [kg]

Body mass index [BMI kg/m2]a

Body fat mass [kg]a

Visceral fat [kg]a

Body fat percentagea

Known first degree relative with T2DM

Known personal History of CHD

Known Gestational diabetes

Known previous result of IFG or IGT, prediabetes or Non-Diabetes Hyperglycaemia

GP surgery address

Participant’s address

Recruitment route

Screening and intervention preferred site

Have they been contacted about the national diabetes prevention programme or equivalent:define

Has the participant been admitted to hospital since their last visit, which has not already been reported and recorded for Serious Adverse Events and Adverse Events [SAE & AE] purposes

  1. ameasured using a Tanita body fat Bio-impedance composition analyser. The Tanita provides an electronic measurement of the body’s composition [tissue and fluid]. [TANITA - Hoogoorddreef, 1101 BE, Amsterdam, The Netherlands. Model BC-420 MA]